Vehicle Cream

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis (Integument-PED)NCT04845620ARQTPhase 3Completed2023-06-01Actual
Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic DermatitisNCT04773587ARQTPhase 3Completed2022-08-30Actual
INM-755 (Cannabinol) Cream for Treatment of Epidermolysis BullosaNCT04908215INMPhase 2Completed2023-04-03Actual
Roflumilast Cream 0.3% for Moderate to Severe Atopic DermatitisNCT07916480ARQTPhase 3Recruiting2028-04-27Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.